Chengdu Starray Therapeutics Co., Ltd

This study is testing a new two-part treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. First, a small radioactive tracer finds the cancer cells. Then, a stronger radioactive drug delivers a targeted dose of ra…